Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00042666
What this trial is testing

Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.

Who this might be right for
Non-Hodgkin's Lymphoma
Eli Lilly and Company 55
Testing effectiveness (Phase 2)Study completedNCT00002522
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Temple University
Early research (Phase 1)UnknownNCT00053105
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Theradex
Testing effectiveness (Phase 2)Ended earlyNCT04718675
What this trial is testing

KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Who this might be right for
Relapsed Solid TumorsRefractory Solid TumorsNon-Hodgkin Lymphoma+2 more
Kronos Bio 135
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Early research (Phase 1)Study completedNCT03259503
What this trial is testing

Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent T-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02625480
What this trial is testing

Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaRelapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Kite, A Gilead Company 95
Testing effectiveness (Phase 2)Looking for participantsNCT05869279
What this trial is testing

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

Who this might be right for
B-cell NHLCLL
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 29
Testing effectiveness (Phase 2)UnknownNCT03250962
What this trial is testing

SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Chinese PLA General Hospital 280
Early research (Phase 1)Study completedNCT02168140
What this trial is testing

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+14 more
Wake Forest University Health Sciences 16
Early research (Phase 1)Ended earlyNCT03403725
What this trial is testing

MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study

Who this might be right for
Metastatic Solid TumorsRelapsed/Refractory Non-Hodgkin Lymphoma
Menarini Group 28
Early research (Phase 1)Ended earlyNCT02106091
What this trial is testing

Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL

Who this might be right for
Relapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
Affimed GmbH 16
Early research (Phase 1)Ended earlyNCT02978235
What this trial is testing

A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma

Who this might be right for
Multiple MyelomaNonHodgkin Lymphoma
Taiho Oncology, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT00474929
What this trial is testing

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507541
What this trial is testing

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent ALK Positive Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+25 more
Mayo Clinic 10
Early research (Phase 1)Study completedNCT06082596
What this trial is testing

Study of BEBT-908 in Subjects With Advanced Hematological Tumors

Who this might be right for
Relapsed or Refractory Non-Hodgkin's LymphomaRelapsed or Refractory Multiple Myeloma
BeBetter Med Inc 32
Testing effectiveness (Phase 2)Study completedNCT00090909
What this trial is testing

Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00014209
What this trial is testing

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 77
Large-scale testing (Phase 3)Ended earlyNCT00060671
What this trial is testing

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, FollicularLymphoma, Mixed-Cell, FollicularLymphoma, Small Cleaved-Cell, Follicular+1 more
CTI BioPharma 800
Early research (Phase 1)Ended earlyNCT01728207
What this trial is testing

Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL

Who this might be right for
Non-hodgkin's LymphomaFollicular LymphomaMantle Cell Lymphoma+3 more
Gilead Sciences 30
Next Page